Company / Return on Equity (ROE)
VitaNova Life Sciences Corp Return on Equity (ROE) History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
80.6%
FY2024
5-year range
80.6% / 80.6%
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
80.6% in FY2024.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 80.6% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -251.8% | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026